 PALO ALTO, Calif., Jan. 07, 2021 GLOBE NEWSWIRE -- Vincerx Pharma, Inc. Nasdaq: VINC, a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has changed its corporate name from Vincera Pharma, Inc. to Vincerx, Inc. The Companys common stock, units and warrants will continue to trade under the current ticker symbols, VINC, VINCW and VINCU, respectively. 